A Strategic, Technology Driven Approach: How RWE Continues to Shape the Late Phase Research Landscape


24th May, 2018
Time: 10:00 - 11:00

Location: Webinar
Timezone: (GMT -5:00) Eastern Time (US & Canada), Bogota, Lima

Due to significant improvements in the integrity, quality and timeliness of data collected, there are a growing number of clinical trials employing electronic media (especially smartphones and tablets) to collect patient-reported outcomes (PROs). Because many PRO instruments were developed and validated on paper, care is needed when migrating them to electronic formats (ePRO) to ensure the measurement properties of the instrument are unchanged, and that the electronic version is easy to use in the target group of patients. In 2009, the ISPOR ePRO Good Research Practices Task Force published recommendations on the evidence needed to support measurement equivalence when migrating from paper to electronic formats, which included cognitive interview and usability testing (minor modifications due to migration) and quantitative equivalence studies (moderate changes). These recommendations have been largely adopted by the industry and regulators. However, over the 8 years since their publication, accumulating evidence has indicated that instrument measurement properties are generally well conserved when instruments are migrated to electronic forms where ePRO design best practice is followed. Does this mean that a qualitative or quantitative study may not always be needed when implementing ePRO?

Key Insights

This webinar will discuss how the availability of varied and robust data assetsis shifting the late phase research landscape. Now more than ever, the ability to make intelligent, strategic decisionsbased on real world evidence is becoming more accessible and readily doable with the right tools. Attendees will gain valuable insights on:

  • The increase in availability of big data from primary and secondary sources and how it is shifting the research landscape
  • The strategic initiatives needed to identify which datasets can answer your research objectives and how to bring them together into one platform
  • The development of a fit-for-purpose RWE technology platform to maximize value from yourdata assets
  • Applying these tactics to an innovative use case

Speakers Include:

Bill Row, MBA, MS
Divisional Principal, Real World Evidence, ICON

 

Bruce Capobianco
Sr. Director, RWE Technology, ICON

 



 

Target Audience

This webinar is intended for pharma, biotech and medical device professionals working in the areas of:

  • Real World Evidence
  • Market Access
  • Pricing and Contracting
  • Technology/RWE IT
  • Epidemiology
  • Health Outcomes and Observational Research (HEOR)

Learn more about how a comprehensive RWE strategy supported by a fit-for-purpose RWE technology platform can deliver the maximum value of real world data.